Please use this identifier to cite or link to this item:
https://scholarbank.nus.edu.sg/handle/10635/49308
Title: | PATIENT-REPORTED OUTCOMES AND PHARMACOECONOMIC ANALYSIS OF PATIENTS TAKING ANTICOAGULANTS IN SINGAPORE | Authors: | WANG YE | Keywords: | Anticoagulants, medication adherence, knowledge, satisfaction, utility assessment, cost-effectiveness analysis | Issue Date: | 16-Aug-2013 | Citation: | WANG YE (2013-08-16). PATIENT-REPORTED OUTCOMES AND PHARMACOECONOMIC ANALYSIS OF PATIENTS TAKING ANTICOAGULANTS IN SINGAPORE. ScholarBank@NUS Repository. | Abstract: | This project had two objectives: 1) to assess patients? medication adherence, knowledge, satisfaction and concerns regarding warfarin therapy, and their associations with the control of International Normalized Ratios (INRs), and 2) to assess the cost-effectiveness of dabigatran and rivaroxaban compared with warfarin in patients with atrial fibrillation (AF), using local utilities in Singapore. This project had several major findings: 1) a patient-reported medication adherence scale was validated; 2) the medication refill adherence was found to be associated with most of the INR measures; 3) patients with better knowledge, higher warfarin adherence, higher satisfaction and fewer concerns were more likely to have better INR control; 4) ischemic stroke and intracranial hemorrhage had a significant impact on patients? health-related quality of life; 5) rivaroxaban was cost-effective compared with warfarin and had extended dominance over dabigatran 150 mg in patients with AF in Singapore. The results were confirmed in the probabilistic sensitivity analysis. | URI: | http://scholarbank.nus.edu.sg/handle/10635/49308 |
Appears in Collections: | Ph.D Theses (Open) |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
WangY.pdf | 2.16 MB | Adobe PDF | OPEN | None | View/Download |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.